Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Cerebellar Transcranial Direct Current Stimulation be Regarded as a Rational Therapeutic Option for Treating Parkinson's Disease ?

NCT07548801 is registered in ClinicalTrials.gov with Université Libre de Bruxelles as lead sponsor.

NCT NCT07548801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07548801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Cerebellar Transcranial Direct Current Stimulation be Regarded as a Rational Therapeutic Option for Treating Parkinson's Disease ?
Lead sponsor
Université Libre de Bruxelles
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
September 24, 2025
Completion date
November 30, 2026
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease (disorder)